R Sanders Williams Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for R Sanders Williams.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of R Sanders Williams. R Sanders Williams is Director in AMGEN INC ($AMGN) and Director in BRISTOL MYERS SQUIBB CO ($BMY) and Director in LABORATORY CORP OF AMERICA HOLDINGS ($LH).
Latest Insider Trading Transactions of R Sanders Williams
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 10 2021 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 251.78 | 250 | 62,945 | 4,409 | 4.7 K to 4.4 K (-5.37 %) |
Feb 08 2021 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 237.99 | 250 | 59,498 | 4,659 | 4.9 K to 4.7 K (-5.09 %) |
Feb 08 2021 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 0.00 | 986 | 0 | 771 | |
Feb 08 2021 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 0.00 | 986 | 0 | 6,232 | 5.2 K to 6.2 K (+18.80 %) |
Feb 04 2021 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 771 | 0 | 1,757 | |
Jan 28 2021 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 98.49 | 1,300 | 128,037 | 0 | |
Jan 28 2021 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 98.49 | 1,300 | 128,037 | 5,246 | 3.9 K to 5.2 K (+32.94 %) |
Jan 28 2021 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Gift | G | 0.00 | 1,149 | 0 | 3,946 | 5.1 K to 3.9 K (-22.55 %) |
Aug 10 2020 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 242.95 | 250 | 60,738 | 5,159 | 5.4 K to 5.2 K (-4.62 %) |
Jul 10 2020 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 98.49 | 1,300 | 128,037 | 1,300 | |
Jul 10 2020 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 173.12 | 1,300 | 225,056 | 5,095 | 6.4 K to 5.1 K (-20.33 %) |
Jul 10 2020 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 98.49 | 1,300 | 128,037 | 6,395 | 5.1 K to 6.4 K (+25.52 %) |
May 07 2020 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 237.31 | 425 | 100,857 | 5,409 | 5.8 K to 5.4 K (-7.28 %) |
May 07 2020 | AMGN | AMGEN INC | Williams R Sanders | Director | Grant | A | 0.00 | 846 | 0 | 5,834 | 5 K to 5.8 K (+16.96 %) |
May 07 2020 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 237.31 | 425 | 100,857 | 5,409 | 5.8 K to 5.4 K (-7.28 %) |
May 07 2020 | AMGN | AMGEN INC | Williams R Sanders | Director | Grant | A | 0.00 | 846 | 0 | 5,834 | 5 K to 5.8 K (+16.96 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 0.00 | 1,227 | 0 | 986 | |
Feb 14 2020 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 188.49 | 1,227 | 231,277 | 5,095 | 6.3 K to 5.1 K (-19.41 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 0.00 | 1,227 | 0 | 6,322 | 5.1 K to 6.3 K (+24.08 %) |
Feb 10 2020 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 233.72 | 425 | 99,331 | 4,988 | 5.4 K to 5 K (-7.85 %) |
Feb 10 2020 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 233.72 | 425 | 99,331 | 4,988 | 5.4 K to 5 K (-7.85 %) |
Feb 06 2020 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 986 | 0 | 2,213 | |
Feb 06 2020 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Gift | G | 0.00 | 1,791 | 0 | 5,095 | 6.9 K to 5.1 K (-26.01 %) |
Nov 07 2019 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 215.45 | 425 | 91,566 | 5,413 | 5.8 K to 5.4 K (-7.28 %) |
Aug 08 2019 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 183.04 | 425 | 77,792 | 5,838 | 6.3 K to 5.8 K (-6.79 %) |
Aug 07 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 162.91 | 500 | 81,455 | 6,886 | 7.4 K to 6.9 K (-6.77 %) |
Aug 07 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 162.91 | 500 | 81,455 | 6,886 | 7.4 K to 6.9 K (-6.77 %) |
May 08 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 162.20 | 500 | 81,100 | 7,386 | 7.9 K to 7.4 K (-6.34 %) |
May 07 2019 | AMGN | AMGEN INC | Williams R Sanders | Director | Grant | A | 0.00 | 1,127 | 0 | 6,263 | 5.1 K to 6.3 K (+21.94 %) |
Feb 14 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 1,227 | |
Feb 14 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
Feb 14 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 147.00 | 1,038 | 152,586 | 7,886 | 8.9 K to 7.9 K (-11.63 %) |
Feb 14 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 0.00 | 1,038 | 0 | 8,924 | 7.9 K to 8.9 K (+13.16 %) |
Nov 29 2018 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 162.14 | 350 | 56,749 | 7,886 | 8.2 K to 7.9 K (-4.25 %) |
May 01 2018 | AMGN | AMGEN INC | Williams R Sanders | Director | Grant | A | 0.00 | 1,127 | 0 | 5,136 | 4 K to 5.1 K (+28.11 %) |
Feb 14 2018 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
Feb 09 2018 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 0.00 | 1,263 | 0 | 0 | |
Feb 09 2018 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 0.00 | 1,263 | 0 | 8,236 | 7 K to 8.2 K (+18.11 %) |
Aug 15 2017 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 77.19 | 3,100 | 239,289 | 0 | |
Aug 15 2017 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 156.92 | 11 | 1,726 | 6,973 | 7 K to 7 K (-0.16 %) |
Aug 15 2017 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 156.91 | 8 | 1,255 | 6,984 | 7 K to 7 K (-0.11 %) |
Aug 15 2017 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 156.90 | 2,881 | 452,021 | 6,992 | 9.9 K to 7 K (-29.18 %) |
Aug 15 2017 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 156.68 | 200 | 31,336 | 9,873 | 10.1 K to 9.9 K (-1.99 %) |
Aug 15 2017 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 77.19 | 3,100 | 239,289 | 10,073 | 7 K to 10.1 K (+44.46 %) |
May 03 2017 | AMGN | AMGEN INC | Williams R Sanders | Director | Grant | A | 0.00 | 1,230 | 0 | 4,009 | 2.8 K to 4 K (+44.26 %) |
Feb 13 2017 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 0.00 | 1,560 | 0 | 1,263 | |
Feb 13 2017 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 0.00 | 1,560 | 0 | 6,973 | 5.4 K to 7 K (+28.82 %) |
Feb 09 2017 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 1,263 | 0 | 2,823 | |
May 05 2016 | AMGN | AMGEN INC | Williams R Sanders | Director | Grant | A | 0.00 | 1,279 | 0 | 2,779 | 1.5 K to 2.8 K (+85.27 %) |
Mar 15 2016 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 0.00 | 1,237 | 0 | 1,560 | |
Mar 15 2016 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 0.00 | 1,237 | 0 | 5,413 | 4.2 K to 5.4 K (+29.62 %) |
Feb 11 2016 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 1,560 | 0 | 2,797 | |
Nov 04 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 64.42 | 1,850 | 119,177 | 0 | |
Nov 04 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 124.33 | 400 | 49,732 | 4,176 | 4.6 K to 4.2 K (-8.74 %) |
Nov 04 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 124.31 | 200 | 24,862 | 4,576 | 4.8 K to 4.6 K (-4.19 %) |
Nov 04 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 124.30 | 100 | 12,430 | 4,776 | 4.9 K to 4.8 K (-2.05 %) |
Nov 04 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 124.29 | 200 | 24,858 | 4,876 | 5.1 K to 4.9 K (-3.94 %) |
Nov 04 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 124.28 | 950 | 118,067 | 5,076 | 6 K to 5.1 K (-15.77 %) |
Nov 04 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 64.42 | 1,850 | 119,177 | 6,026 | 4.2 K to 6 K (+44.30 %) |
May 14 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 118.10 | 102 | 12,046 | 4,176 | 4.3 K to 4.2 K (-2.38 %) |
May 14 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 118.08 | 100 | 11,808 | 4,278 | 4.4 K to 4.3 K (-2.28 %) |
May 14 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 118.06 | 200 | 23,612 | 4,378 | 4.6 K to 4.4 K (-4.37 %) |
May 14 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 118.05 | 100 | 11,805 | 4,578 | 4.7 K to 4.6 K (-2.14 %) |
May 14 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 118.02 | 463 | 54,643 | 4,678 | 5.1 K to 4.7 K (-9.01 %) |
Apr 28 2015 | AMGN | AMGEN INC | Williams R Sanders | Director | Grant | A | 0.00 | 1,191 | 0 | 1,500 | 309 to 1.5 K (+385.44 %) |
Mar 13 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 1,237 | 0 | 1,237 | |
Mar 02 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 123.97 | 1,300 | 161,156 | 5,141 | 6.4 K to 5.1 K (-20.18 %) |
Mar 02 2015 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 123.96 | 967 | 119,869 | 6,441 | 7.4 K to 6.4 K (-13.05 %) |
May 14 2010 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 77.19 | 3,100 | 239,289 | 3,100 | |
May 14 2010 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 0.00 | 900 | 0 | 3,812 | 2.9 K to 3.8 K (+30.91 %) |
May 08 2009 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 64.42 | 3,700 | 238,354 | 3,700 | |
May 08 2009 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 0.00 | 1,100 | 0 | 2,912 | 1.8 K to 2.9 K (+60.71 %) |
May 09 2008 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 75.63 | 5,300 | 400,839 | 5,300 | |
May 09 2008 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 0.00 | 900 | 0 | 1,812 | 912 to 1.8 K (+98.68 %) |
May 07 2008 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 74.25 | 22 | 1,634 | 912 | 890 to 912 (+2.47 %) |
Apr 03 2008 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 74.90 | 22 | 1,648 | 890 | 868 to 890 (+2.53 %) |
Apr 02 2008 | BMY | BRISTOL MYERS SQUI ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 632 | 0 | 11,249 | |
Mar 05 2008 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 79.29 | 21 | 1,665 | 868 | 847 to 868 (+2.48 %) |
Feb 05 2008 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 73.08 | 22 | 1,608 | 847 | 825 to 847 (+2.67 %) |
Jan 18 2008 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 76.70 | 21 | 1,611 | 825 | 804 to 825 (+2.61 %) |
Feb 05 2008 | BMY | BRISTOL MYERS SQUI ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 4,648 | 0 | 10,617 | |
Jan 03 2008 | BMY | BRISTOL MYERS SQUI ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 442 | 0 | 5,795 | |
Dec 05 2007 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 69.59 | 23 | 1,601 | 804 | 781 to 804 (+2.94 %) |
Nov 05 2007 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 75.89 | 21 | 1,594 | 781 | 760 to 781 (+2.76 %) |
Oct 03 2007 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 76.92 | 21 | 1,615 | 760 | 739 to 760 (+2.84 %) |
Oct 02 2007 | BMY | BRISTOL MYERS SQUI ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 376 | 0 | 5,303 | |
Sep 06 2007 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 75.85 | 21 | 1,593 | 739 | 718 to 739 (+2.92 %) |
Aug 03 2007 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 78.42 | 21 | 1,647 | 718 | 697 to 718 (+3.01 %) |
Jul 03 2007 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 78.70 | 21 | 1,653 | 697 | 676 to 697 (+3.11 %) |
Jul 03 2007 | BMY | BRISTOL MYERS SQUI ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 408 | 0 | 4,879 | |
Jun 05 2007 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 78.59 | 21 | 1,650 | 676 | 655 to 676 (+3.21 %) |
Jun 05 2007 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 72.53 | 11 | 798 | 655 | 644 to 655 (+1.71 %) |
May 18 2007 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 77.58 | 992 | 76,959 | 992 | |
May 18 2007 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Grant | A | 0.00 | 644 | 0 | 644 | 0 to 644 |
Apr 03 2007 | BMY | BRISTOL MYERS SQUI ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 428 | 0 | 4,429 | |
Feb 05 2007 | BMY | BRISTOL MYERS SQUI ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 3,500 | 0 | 4,001 | |
Jan 03 2007 | BMY | BRISTOL MYERS SQUI ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 404 | 0 | 496 | |
Oct 03 2006 | BMY | BRISTOL MYERS SQUI ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 91 | 0 | 91 |
Page: 1